MedTrace Logo

Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease

NCT02950610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2018-06-26

No results posted yet for this study

Summary

The purpose of this is to analyse human exhaled breath by means of a device called electronic nose(eNose) in patients with non-alcoholic fatty liver disease (NAFLD) as a way to non-invasive assessment of liver disease.This device is medically adapted and clinically validated in patients with lung conditions.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

DEVICE

Breath analysis - electronic signature "Breath-print"

Patients and Healthy volunteers ( as defined in 3 cohorts) will breath into disposable, once-use only bacterial filter channeled into electronic device comprising on sensors capable to reacting to organic compounds. Breathing manoeuvre will be simple, non-exertional and relaxed. 2 breathing manoeuvres will be performed and sensor responses will be captured.

Sponsors & Collaborators

  • University of Strathclyde

    collaborator OTHER

  • University of Amsterdam

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Peter C Hayes, MD,PhD,FRCPE · Centre for liver and digestive disorder, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-08-31
Completion
2018-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950610 on ClinicalTrials.gov